Strategic Marketing Consultant~Bridge R&D and Commercialization for Sustainable Global Branding

Summary

Deb Alper
Global Marketing leader who works to identify the most effective and efficient methods that drive consensus and solutions. Recognized as a trusted advisor, managing end to end commercialization from discovery through launch, resulting in optimal patient outcomes.

➤ PHARMA / BIOTECH: Alper Consulting partners with oncology companies that seek commercial guidance and assists commercial divisions of pharmaceutical companies with strategic planning, new product launch preparation, early to late phase commercialization, life cycle planning and portfolio prioritization.

➤ AGENCY / VENDOR: Alper Consulting works with agencies and pharma / biotech vendors as a support team member or project lead to expand their capacity, deliverables, and deepen skill sets for clients. Contact: DebAlper@Optimum.net

Timeline

  1. -
    Director, Strategic Portfolio Analysis, Johnson & Johnson

    Partnered with the oncology senior leadership strategy team and guided prioritization across the oncology portfolio.  Restructured and improved prioritization process by creating an objective method and annual assessment.  Ran clinical trial benchmarking and PTRS (probability of technical and regulatory success) exercises with project teams that drove more objective discussions, improving transparency and believability of risk assessments. 

  2. -
    Director, Global Strategic Marketing Hematology, Johnson & Johnson

    Led the global commercial launch of the first compound (Sylvant, siltuximab) indicated for an ultra-orphan indication (Multicentric Castlemans Disease) treated by hematologists . Co-led global commercial launch of the first in class monoclonal antibody for the treatment of multiple myeloma (Darzalex, daratumumab) that achieved >$1B in first year sales. This included creation of a brand vision and messaging for both compounds that changed the treatment paradigm in the respective diseases.

  3. -
    Strategic Marketing Consultant, Alper Consulting LLC

    Deb Alper is a global marketing leader who blends customer focused insights across departments including Research, Development, Regulatory, Medical Affairs, Market Access, Supply Chain, Project Management, and Communications and identifies the most effective and efficient methods that drive consensus and solutions. Recognized as a trusted advisor, managing end to end commercialization, from discovery through launch, resulting in optimal patient outcomes.

    Oncology, Hematology, Rare Diseases

Services

  • Market Research
  • brand visions
  • Positioning Statements
  • SWOT Analysis
  • project management
  • business development
  • market assessments
  • Target product profiles
  • life cycle managment
  • Global product Launch
  • Competitive Intelligence
  • New Product planning